PMID: 9448313Mar 14, 1998Paper

PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims

Proceedings of the National Academy of Sciences of the United States of America
P J JacksonP Keim

Abstract

An outbreak of human anthrax occurred in Sverdlovsk, Union of Soviet Socialists Republic (now Ekaterinburg, Russia) in April 1979. Officials attributed this to consumption of contaminated meat, but Western governments believed it resulted from inhalation of spores accidentally released from a nearby military research facility. Tissue samples from 11 victims were obtained and methods of efficiently extracting high-quality total DNA from these samples were developed. Extracted DNA was analyzed by using PCR to determine whether it contained Bacillus anthracis-specific sequences. Double PCR using "nested primers" increased sensitivity of the assay significantly. Tissue samples from 11 persons who died during the epidemic were examined. Results demonstrated that the entire complement of B. anthracis toxin and capsular antigen genes required for pathogenicity were present in tissues from each of these victims. Tissue from a vaccination site contained primarily nucleic acids from a live vaccine, although traces of genes from the infecting organisms were also present. PCR analysis using primers that detect the vrrA gene variable region on the B. anthracis chromosome demonstrated that at least four of the five known strain categories de...Continue Reading

References

Feb 1, 1985·Journal of General Microbiology·I UchidaN Terakado
Mar 1, 1985·Infection·H Knothe, G A Dette
May 1, 1986·Infection and Immunity·B E IvinsS H Leppla
Aug 1, 1985·Infection and Immunity·B D GreenB E Ivins
Nov 18, 1994·Science·M MeselsonO Yampolskaya
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·F A AbramovaD H Walker

❮ Previous
Next ❯

Citations

Jan 5, 2000·American Journal of Physical Anthropology·C J Kolman, N Tuross
Apr 12, 2005·International Journal of Legal Medicine·Bruce BudowleRanajit Chakraborty
Oct 28, 2003·The American Journal of Pathology·Wun-Ju ShiehUNKNOWN Anthrax Bioterrorism Investigation Team
Sep 5, 2002·Clinics in Dermatology·C Anthony Hart, Nicholas J Beeching
Mar 24, 1999·Ryōikibetsu shōkōgun shirīzu·K WatanabeR Shirakawa
May 11, 2002·Research in Microbiology·Guy PatraMichèle Mock
Feb 24, 2001·Biosensors & Bioelectronics·S S IqbalJ P Chambers
Jun 6, 2003·Biosensors & Bioelectronics·James A HigginsRonald P Koopman
Aug 9, 2006·Epidemiology and Infection·Z F DembekJ A Pavlin
Dec 21, 2004·Nature Reviews. Microbiology·Michel Drancourt, Didier Raoult
Sep 9, 1999·The New England Journal of Medicine·T C DixonP C Hanna
Nov 13, 2001·The New England Journal of Medicine·M N Swartz
Mar 17, 2010·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Willy A Valdivia-Granda
Dec 24, 2009·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Jonathan B Tucker, Gregory D Koblentz
Jun 21, 2006·Applied Immunohistochemistry & Molecular Morphology : AIMM·Kathleen M TattiSherif R Zaki
Nov 25, 2004·Antimicrobial Agents and Chemotherapy·Yahua ChenTheresa M Koehler
Aug 4, 2006·Applied and Environmental Microbiology·Maya MerabishviliDaniele Daffonchio
Dec 18, 2007·Applied and Environmental Microbiology·Thomas E MacdonaldKaren K Hill
Nov 1, 2002·Journal of Clinical Microbiology·Steven M LevineMartin J Blaser
Jul 5, 2003·Journal of Clinical Microbiology·Kwan Soo KoYoon-Hoh Kook
Mar 1, 2003·Journal of Clinical Pathology·R C Spencer
Sep 20, 2005·PLoS Medicine·Steven E SchutzerRonald M Atlas
Sep 1, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Stephen F Little
Jul 1, 2010·Arhiv za higijenu rada i toksikologiju·Ante Vucemilović
Apr 9, 2008·Emerging Infectious Diseases·Richard T OkinakaPaul Keim
Nov 15, 2000·Lancet·S H RingertzK Fossum
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·M DrancourtD Raoult
May 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Dean A Wilkening
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Anna GoldenbergStephen E Fienberg
Nov 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·D RaoultM Drancourt
Feb 27, 2013·Memórias do Instituto Oswaldo Cruz·Viviane ZahnerIvano de Filippis
Aug 7, 2003·Critical Reviews in Microbiology·Jack Woodall
Sep 15, 2009·Veterinary Microbiology·Antonio FasanellaMartin Hugh Jones
Jun 10, 2006·Infectious Disease Clinics of North America·Stephen A Morse, Bruce Budowle
Jul 13, 2004·Diagnostic Microbiology and Infectious Disease·Dmitriy VolokhovVladimir Chizhikov
Nov 4, 2004·Biosensors & Bioelectronics·James PannucciRobert B Cary

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
F A AbramovaD H Walker
Emerging Infectious Diseases
J A JerniganAnthrax Bioterrorism Investigation Team
© 2021 Meta ULC. All rights reserved